Swipe om te navigeren naar een ander artikel
Symptom progression in Huntington disease (HD) is associated with cognitive decline which may interfere with the self-report of symptoms. Unfortunately, data to support or refute the psychometric reliability of patient-reported outcomes (PROs) as HD progresses are limited. This is problematic given that PROs are increasingly recognized as important measures of efficacy for new treatments.
We examined PRO data from the HDQLIFE Measurement System (Speech Difficulties; Swallowing Difficulties; Chorea) in 509 individuals with premanifest, early-stage, or late-stage HD. Clinician-administered assessments of motor functioning (items from the UHDRS) and standardized objective assessments of cognition (Stroop, Symbol Digit Modalities) were also collected. We examined item bias using differential item functioning (DIF) across HD stage (premanifest, early-, late-) and relative to cognitive performance. We also examined the correlations between self-report and clinician ratings. Regression models that considered total cognitive ability were utilized to determine psychometric reliability of the PROs.
Most PRO items were free from DIF for both staging and cognition. There were modest correlations between PROs and clinician report (ranged from − 0.40 to − 0.60). Modeling analyses indicated that psychometric reliability breaks down with poorer cognition and more progressed disease stage; split-half reliability was compromised (i.e., split-half reliability < 0.80) when scores were < 136 for Chorea, < 109 for Speech Difficulties, and < 179 for Swallowing Difficulties.
Results indicate that the psychometric reliability of PROs can be compromised as HD symptoms progress and cognition declines. Clinicians should consider PROs in conjunction with other types of assessments when total cognition scores exceed critical thresholds.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
The Huntington’s Disease Collaborative Research Group, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 1993. 72: 971–983. CrossRef
Squitieri, F., et al.(2015). Epidemiology of Huntington disease: first post-HTT gene analysis of prevalence in Italy. Clinical Genetics, 89(3), 367–370.
Evans, S. J. W., et al. (2013). Prevalence of adult Huntington’s disease in the UK based on diagnoses recorded in general practice records. Journal of Neurology Neurosurgery and Psychiatry, 84(10), 1156–1160. CrossRef
Paulsen, J. S. Early Detection of Huntington Disease. Future Neurology, 2010. 5(1), 85–104. CrossRef
Ross, C. A., et al. (1997). Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). Medicine (Baltimore), 76(5), 305–338. CrossRef
Cella, D. F. (1995). Measuring quality of life in palliative care. Seminars in oncology, 22(2 Suppl 3), 73–81. PubMed
Cella, D. F., et al. (2011). The Neurology Quality of Life Measurement (Neuro-QOL) initiative. Archives of Physical Medicine and Rehabilitation, Supplement., 92(Suppl 1), S28-S36.
Cella, D. F., et al. (2007). The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Medical Care, 45(5 Suppl 1), S3–S11.
Carlozzi, N. E., et al.(2016). The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea. Quality of Life Research, 25(20), 2429–2439.
Carlozzi, N. E., et al. (2016). HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties. Quality of Life Research, 25(10), 2417–2427.
Carlozzi, N. E., et al.(2016). New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system). Quality of Life Research, 25(10), 2403–2415.
Stout, J. C., et al. (2012). Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington’s disease. Journal of Neurology Neurosurgery Psychiatry, 12(7), 687–694. CrossRef
Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20(1), 10. CrossRef
Paulsen, J. S., et al. (2008). Detection of Huntington’s disease decades before diagnosis: the Predict-HD study. Journal of Neurology, Neurosurgery & Psychiatry, 79(8), 874–880. CrossRef
Hanauer, D. A., et al. (2015). Supporting information retrieval from electronic health records: A report of University of Michigan’s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). Journal of Biomedical Informatics, 55, 290–300. CrossRefPubMedPubMedCentral
Huntington Study Group, (1996). Unified Huntington’s disease rating scale: Reliability and consistency. Movement Disorders, 11(2): 136–142. CrossRef
Stroop, J. R. (1992). Studies of interference in serial verbal reactions (Reprinted from Journal Experimental-Psychology, Vol 18, Pg 643–662, 1935). Journal of Experimental Psychology: General, 121(1), 15. CrossRef
Smith, A. (1995). Symbol Digit Modalities Test: Manual. Los Angeles: Western Psychological Services.
Crane, P. K., et al. (2006). Differential item functioning analysis with ordinal logistic regression techniques. DIFdetect and difwithpar. Medical Care, 44(11 Suppl 3), S115-S123.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences ( 2nd edition). New York: Academic Press.
DeVellis, R. (2017) Scale development: Theory and applications. In L. Bickman & D. J. Rog (Eds.) Applied social research methods series, 4th edn. Los Angeles: Sage.
Dorsey, E. R., et al. (2013). Natural history of Huntington disease. JAMA Neurol, 70(12), 1520–1530. PubMed
McCusker, E., & Loy, C. T. (2014). The many facets of unawareness in Huntington disease. Tremor Other Hyperkinet Mov (N Y), 4, 257.
Folstein, S. E..(1989). Huntington’s disease: A disorder of families. Baltimore :Johns Hopkins University Press.
Hayden, M. R., MacGregor, J. M., & Beighton, P. H. (1980). The prevalence of Huntington’s chorea in South Africa. South African Medical Journal, 58, 193–196. PubMed
Narabayashi, H. (1973). Huntington’s chorea in Japan: Review of the literature. Advances in neurology, 1, 253–259.
- Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?
N. E. Carlozzi
A. L. Kratz
J. S. Paulsen
J. C. Stout
- Springer International Publishing